Fierce Pharma19h
For struggling cell and gene therapy field, Peter Marks' FDA exit adds even more uncertainty
The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...
Nanostructuring MOF crystals unlocks their potential, retaining electrical properties with enhanced sensitivity
Scientists at IMDEA Nanociencia are working on the development of materials whose properties can change as easily as we flip ...
Extracellular vesicles as a cellular tracking tool could yield new therapies for polycystic kidney disease
For patients with polycystic kidney disease (PKD), a common genetic disorder that ravages the waste-removing organ with cysts ...